NCT04340037

Brief Summary

We aim to determine the preoperative predictors of sepsis after percutaneous nephrolithotomy (PCNL) in patients with unilateral, solitary and proximal ureteral stones.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
745

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 7, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 9, 2020

Completed
Last Updated

April 9, 2020

Status Verified

April 1, 2020

Enrollment Period

10 months

First QC Date

April 7, 2020

Last Update Submit

April 7, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • sepsis

    the concurrence of infection and a minimum of two of the following within 48 hours of surgery: (1) heart rate \>90/minute, (2) body temperature \>38°C, (3) leukocyte count \<4,000 cells/μL or \>12,000 cells/μL, and (4) respiratory rate \>20/minute

    within 48 hour after surgery

Study Arms (1)

proximal ureteral stone patient

Patients underwent percutaneous nephrolithotomy treating unilateral, solitary and proximal ureteral stones.

Procedure: percutaneous nephrolithotomy

Interventions

percutaneous surgery using nephroscope

proximal ureteral stone patient

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A total of 745 patients who underwent PCNL from January 2012 to December 2018 were enrolled when meeting eligibility criteria

You may qualify if:

  • (1) PCNL was performed to treat unilateral, solitary, and proximal ureteral stones; and (2) age ≥18 years

You may not qualify if:

  • anatomical renal abnormalities (horseshoe kidney, solitary kidney, transplant kidney and kidney duplication)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430030, China

Location

MeSH Terms

Conditions

InfectionsUrolithiasis

Interventions

Nephrolithotomy, Percutaneous

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

LaparoscopyEndoscopyMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeUrologic Surgical ProceduresUrogenital Surgical Procedures

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 7, 2020

First Posted

April 9, 2020

Study Start

March 1, 2019

Primary Completion

January 1, 2020

Study Completion

February 20, 2020

Last Updated

April 9, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

The data is not suitable to be public

Locations